OR WAIT null SECS
Growth and Advancements in Fill/Finish
Leveraging automation advancements can help improve efficiency in aseptic processing.
Changes and Trends in the Outsourcing Landscape
Quality Considerations in Changing Excipient Providers
January 09, 2024
The potential for superpotent drug initiated the voluntary recall.
The expansion will boost solid-phase peptide synthesis total reactor volume to 32,000 L.
January 08, 2024
Societal™ CDMO's J. David Enloe and Erica Raether discuss the fundamentals of maintaining a strong company culture during times of change.
January 05, 2024
MediWound has been granted an additional $6.7 million by the DoD to advance NexoBrid as a non-surgical field care solution for the US military.
Under the collaboration, Boehringer Ingelheim and Ribo will develop RNA-based therapeutics to treat NASH/MASH.
January 04, 2024
Roche will acquire select parts of the LumiraDx group related to that company’s point-of-care technology, which integrates multiple tests on a single instrument.
AstraZeneca’s acquisition of Gracell includes a clinical-stage autologous cell therapy targeting hematologic malignancies and autoimmune diseases and a proprietary manufacturing platform.
The new Europe headquarters will be the hub for the company’s European operations, including production of product.
January 03, 2024
Revolutionary therapies restructure pharmaceutical manufacturing.
European bio/pharma companies have no choice but to invest and adapt to the evolving industry needs.